Pyxis Oncology (PYXS) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Pyxis Oncology (PYXS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 460K (-94.90%) | 9.02M (+1071.43%) | 770K (-72.70%) | 2.82M (+127.42%) | 1.24M | -3.87M | 1.85M (-8.42%) | 2.02M (-87.49%) | 16M (+915.72%) | 1.59M (-7.02%) | 1.71M (+3.01%) | 1.66M (-0.60%) | 1.67M (-10.70%) | 1.87M (+159.72%) | 720K (+350.00%) | 160K (+1500.00%) | 10K | - | - | - | - | - | - | - | - |
Cost Of Revenue | - | 2.39M | - | - | - | - | - | - | 480K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Costof Goods And Services Sold | - | 2.39M | - | - | - | - | - | - | 480K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | 11M | - | - | - | - | - | - | 16M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 20M (-7.97%) | 22M (+21.90%) | 18M (+3.97%) | 17M (+0.53%) | 17M (+21.54%) | 14M (-20.97%) | 18M (+27.17%) | 14M (+7.06%) | 13M (+12.23%) | 12M (-20.97%) | 15M (+28.97%) | 11M (-4.29%) | 12M (-60.13%) | 30M (+56.86%) | 19M (+10.83%) | 17M (-14.45%) | 20M (+177.59%) | 7.23M (-7.90%) | 7.85M (+144.55%) | 3.21M (-90.20%) | 33M (+395.02%) | 6.62M (+173.55%) | 2.42M | - | - |
Selling General And Administrative | 4.38M (-16.25%) | 5.23M (-7.43%) | 5.65M (+3.86%) | 5.44M (-7.33%) | 5.87M (+15.55%) | 5.08M (-15.47%) | 6.01M (-1.15%) | 6.08M (-26.30%) | 8.25M (+33.93%) | 6.16M (-42.27%) | 11M (+58.54%) | 6.73M (-25.64%) | 9.05M (+11.45%) | 8.12M (-13.25%) | 9.36M (+9.35%) | 8.56M (-24.38%) | 11M (+23.04%) | 9.20M (+144.03%) | 3.77M (+37.59%) | 2.74M (-7.43%) | 2.96M (-3.90%) | 3.08M (+300.00%) | 770K | - | - |
Operating Expenses | 24M (-9.61%) | 27M (+14.88%) | 23M (+3.94%) | 23M (-1.48%) | 23M (+19.88%) | 19M (-19.54%) | 24M (+18.57%) | 20M (-5.87%) | 21M (+19.75%) | 18M (-29.90%) | 25M (+39.90%) | 18M (-13.51%) | 21M (-44.82%) | 38M (+33.74%) | 28M (+10.34%) | 26M (-18.03%) | 31M (+91.05%) | 16M (+41.39%) | 12M (+95.62%) | 5.94M (-83.38%) | 36M (+268.35%) | 9.70M (+204.08%) | 3.19M | - | - |
Depreciation And Amortization | 460K (-88.38%) | 3.96M | - | - | 550K (-70.59%) | 1.87M | - | - | 1.12M (-35.63%) | 1.74M | - | - | 190K (-65.45%) | 550K | - | - | 160K (-69.81%) | 530K | - | - | 110K (-76.60%) | 470K | - | - | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -24.36M (+33.11%) | -18.30M (-21.99%) | -23.46M (+18.78%) | -19.75M (-13.79%) | -22.91M (-42.83%) | -40.07M (+68.72%) | -23.75M (+18.57%) | -20.03M (+257.68%) | -5.60M (-68.49%) | -17.77M (-29.90%) | -25.35M (+39.90%) | -18.12M (-13.51%) | -20.95M (-44.82%) | -37.97M (+33.74%) | -28.39M (+10.34%) | -25.73M (-18.03%) | -31.39M (+91.05%) | -16.43M (+41.39%) | -11.62M (+95.62%) | -5.94M (-83.38%) | -35.73M (+268.35%) | -9.70M (+204.08%) | -3.19M | - | - |
Ebit | -24.36M (+33.11%) | -18.30M (-21.99%) | -23.46M (+18.78%) | -19.75M (-13.79%) | -22.91M (-42.83%) | -40.07M (+68.72%) | -23.75M (+18.57%) | -20.03M (+257.68%) | -5.60M (-68.49%) | -17.77M (-29.90%) | -25.35M (+39.90%) | -18.12M (-13.51%) | -20.95M (-44.82%) | -37.97M (+33.74%) | -28.39M (+10.34%) | -25.73M (-18.03%) | -31.39M (+91.05%) | -16.43M (+41.39%) | -11.62M (+95.62%) | -5.94M (-83.38%) | -35.73M (+670.04%) | -4.64M (+45.45%) | -3.19M (+2.90%) | -3.10M (+58.16%) | -1.96M |
EBITDA | -23.90M (+36.81%) | -17.47M (-20.59%) | -22.00M (+21.75%) | -18.07M (-19.19%) | -22.36M (-48.57%) | -43.48M (+105.09%) | -21.20M (+22.54%) | -17.30M (+285.30%) | -4.49M (-78.15%) | -20.55M (-10.85%) | -23.05M (+44.97%) | -15.90M (-23.41%) | -20.76M (-45.80%) | -38.30M (+38.42%) | -27.67M (+8.26%) | -25.56M (-18.16%) | -31.23M (+180.59%) | -11.13M (-21.45%) | -14.17M (+73.87%) | -8.15M (-77.12%) | -35.62M (+752.15%) | -4.18M (+31.03%) | -3.19M (+2.90%) | -3.10M (+58.16%) | -1.96M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 220K (-4.35%) | 230K (-4.17%) | 240K (+140.00%) | 100K (+25.00%) | 80K (-11.11%) | 90K (-52.63%) | 190K (-51.28%) | 390K (+50.00%) | 260K (+73.33%) | 150K (-34.78%) | 230K (-42.50%) | 400K (-62.62%) | 1.07M (-42.78%) | 1.87M (+159.72%) | 720K (+350.00%) | 160K (+1500.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - | 70K | - | - | - |
Net Interest Income | 220K (-4.35%) | 230K (-4.17%) | 240K (+140.00%) | 100K (+25.00%) | 80K (-11.11%) | 90K (-52.63%) | 190K (-51.28%) | 390K (+50.00%) | 260K (+73.33%) | 150K (-34.78%) | 230K (-42.50%) | 400K (-62.62%) | 1.07M (-42.78%) | 1.87M (+159.72%) | 720K (+350.00%) | 160K (+1500.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - | 70K | - | - | - |
Other Non Operating Income | 1.09M (-82.39%) | 6.19M (+323.97%) | 1.46M (-13.10%) | 1.68M (-4.55%) | 1.76M (-82.35%) | 9.97M (+290.98%) | 2.55M (-6.59%) | 2.73M (+16.17%) | 2.35M (-72.06%) | 8.41M (+264.07%) | 2.31M (+4.05%) | 2.22M (+29.82%) | 1.71M (-38.04%) | 2.76M (+283.33%) | 720K (+350.00%) | 160K (+1500.00%) | 10K | -6.03M (+136.47%) | -2.55M (+29.44%) | -1.97M (+79.09%) | -1.10M | 70K | - | - | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | - | -38.16M (+73.45%) | -22.00M (+21.75%) | -18.07M | - | -40.99M (+93.35%) | -21.20M (+22.54%) | -17.30M | - | -73.79M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Income Tax Expense | - | 1.10M | - | 280K | - | -2.16M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -23.27M (+28.49%) | -18.11M (-17.68%) | -22.00M (+19.89%) | -18.35M (-13.28%) | -21.16M (-40.51%) | -35.57M (+67.78%) | -21.20M (+22.54%) | -17.30M (+430.67%) | -3.26M (-79.10%) | -15.60M (-32.32%) | -23.05M (+44.97%) | -15.90M (-17.36%) | -19.24M (-46.70%) | -36.10M (+30.47%) | -27.67M (+8.26%) | -25.56M (-18.55%) | -31.38M (+86.45%) | -16.83M (+18.77%) | -14.17M (+73.87%) | -8.15M (-77.87%) | -36.83M (+704.15%) | -4.58M (+43.57%) | -3.19M (+2.90%) | -3.10M (+58.16%) | -1.96M |
Net Income | -23.27M (+28.49%) | -18.11M (-17.68%) | -22.00M (+19.89%) | -18.35M (-13.28%) | -21.16M (-40.51%) | -35.57M (+67.78%) | -21.20M (+22.54%) | -17.30M (+430.67%) | -3.26M (-79.10%) | -15.60M (-32.32%) | -23.05M (+44.97%) | -15.90M (-17.36%) | -19.24M (-46.70%) | -36.10M (+30.47%) | -27.67M (+8.26%) | -25.56M (-18.55%) | -31.38M (+86.45%) | -16.83M (+18.77%) | -14.17M (+73.87%) | -8.15M (-77.87%) | -36.83M (+704.15%) | -4.58M (+43.57%) | -3.19M (+2.90%) | -3.10M (+58.16%) | -1.96M |
Comprehensive Income Net Of Tax | -23.32M (-70.75%) | -79.74M (+263.61%) | -21.93M (+19.12%) | -18.41M (-13.49%) | -21.28M (-72.44%) | -77.22M (+272.14%) | -20.75M (+19.67%) | -17.34M (+413.02%) | -3.38M (-95.42%) | -73.73M (+219.59%) | -23.07M (+38.31%) | -16.68M (-10.08%) | -18.55M (-84.63%) | -120.72M (+336.28%) | -27.67M (+8.26%) | -25.56M (-18.55%) | -31.38M | - | - | - | - | - | - | - | - |